Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 113

1.

The longitudinal association between depressive symptoms and initiation of insulin therapy in people with type 2 diabetes in primary care.

Nefs G, Pop VJ, Denollet J, Pouwer F.

PLoS One. 2013 Nov 1;8(11):e78865. doi: 10.1371/journal.pone.0078865. eCollection 2013.

2.

Anxiety, depression and timing of insulin treatment among people with type 2 diabetes: Nine-year follow-up of the Nord-Trøndelag Health Study, Norway.

Iversen MM, Nefs G, Tell GS, Espehaug B, Midthjell K, Graue M, Pouwer F.

J Psychosom Res. 2015 Oct;79(4):309-15. doi: 10.1016/j.jpsychores.2015.07.004. Epub 2015 Jul 16.

PMID:
26208403
3.
4.

Time to and factors associated with insulin initiation in patients with type 2 diabetes mellitus.

Machado-Alba JE, Machado-Duque ME, Moreno-Gutierrez PA.

Diabetes Res Clin Pract. 2015 Mar;107(3):332-7. doi: 10.1016/j.diabres.2015.01.018. Epub 2015 Jan 21.

PMID:
25648389
5.

Time to insulin treatment and factors associated with insulin prescription in Swedish patients with type 2 diabetes.

Ringborg A, Lindgren P, Yin DD, Martinell M, Stålhammar J.

Diabetes Metab. 2010 Jun;36(3):198-203. doi: 10.1016/j.diabet.2009.11.006. Epub 2010 Mar 28.

PMID:
20347376
6.

Barriers towards insulin therapy in type 2 diabetic patients: results of an observational longitudinal study.

Hermanns N, Mahr M, Kulzer B, Skovlund SE, Haak T.

Health Qual Life Outcomes. 2010 Oct 4;8:113. doi: 10.1186/1477-7525-8-113.

7.

Predictors for the initiation of a basal supported oral therapy (BOT) in type 2 diabetic patients under real-life conditions in Germany.

Kostev K, Dippel FW.

Prim Care Diabetes. 2012 Dec;6(4):329-35. doi: 10.1016/j.pcd.2012.06.001. Epub 2012 Jun 30.

PMID:
22749713
9.

Does an advanced insulin education programme improve outcomes and health service use for people with Type 2 diabetes? A 5-year follow-up of the Newcastle Empowerment course.

Lowe JM, Mensch M, McElduff P, Fitzgerald M, Attia J.

Diabet Med. 2009 Dec;26(12):1277-81. doi: 10.1111/j.1464-5491.2009.02858.x.

PMID:
20002481
10.

Well-being and symptoms in relation to insulin therapy in type 2 diabetes.

de Sonnaville JJ, Snoek FJ, Colly LP, Devillé W, Wijkel D, Heine RJ.

Diabetes Care. 1998 Jun;21(6):919-24.

PMID:
9614608
11.

Changes in depressive symptoms and glycemic control in diabetes mellitus.

Georgiades A, Zucker N, Friedman KE, Mosunic CJ, Applegate K, Lane JD, Feinglos MN, Surwit RS.

Psychosom Med. 2007 Apr;69(3):235-41. Epub 2007 Apr 9.

PMID:
17420441
12.

Depressive symptoms predict non-completion of a structured exercise intervention for people with Type 2 diabetes.

Swardfager W, Yang P, Herrmann N, Lanctôt KL, Shah BR, Kiss A, Oh PI.

Diabet Med. 2016 Apr;33(4):529-36. doi: 10.1111/dme.12872. Epub 2015 Aug 25.

PMID:
26220364
13.

Impact of diabetes mellitus and insulin use on survival after colorectal cancer diagnosis: the Cancer Prevention Study-II Nutrition Cohort.

Dehal AN, Newton CC, Jacobs EJ, Patel AV, Gapstur SM, Campbell PT.

J Clin Oncol. 2012 Jan 1;30(1):53-9. doi: 10.1200/JCO.2011.38.0303. Epub 2011 Nov 28.

PMID:
22124092
14.

Persistence with injectable antidiabetic agents in members with type 2 diabetes in a commercial managed care organization.

Cooke CE, Lee HY, Tong YP, Haines ST.

Curr Med Res Opin. 2010 Jan;26(1):231-8. doi: 10.1185/03007990903421994.

PMID:
19921965
15.

Comparison of biphasic insulin aspart 30 given three times daily or twice daily in combination with metformin versus oral antidiabetic drugs alone in patients with poorly controlled type 2 diabetes: a 16-week, randomized, open-label, parallel-group trial conducted in russia.

Ushakova O, Sokolovskaya V, Morozova A, Valeeva F, Zanozina O, Sazonova O, Zhadanova E, Starceva M, Kazakova E, Saifullina M, Shapiro I, Tarasov A, Al-Tayar B, Starkova N.

Clin Ther. 2007 Nov;29(11):2374-84.

PMID:
18158078
16.

Progression to insulin for patients with diabetes mellitus using the Texas Medicaid database.

Rascati KL, Richards KM, Lopez D, Cheng LI, Wilson JP.

Clin Ther. 2011 Dec;33(12):2016-20. doi: 10.1016/j.clinthera.2011.10.018. Epub 2011 Nov 21.

PMID:
22101160
18.

Time to insulin initiation and long-term effects of initiating insulin in people with type 2 diabetes mellitus: the Hoorn Diabetes Care System Cohort Study.

Mast R, Danielle Jansen AP, Walraven I, Rauh SP, van der Heijden AA, Heine RJ, Elders PJ, Dekker JM, Nijpels G, Hugtenburg JG.

Eur J Endocrinol. 2016 May;174(5):563-71. doi: 10.1530/EJE-15-1149. Epub 2016 Feb 2.

19.

Initiation of insulin glargine in patients with Type 2 diabetes in suboptimal glycaemic control positively impacts health-related quality of life. A prospective cohort study in primary care.

Hajos TR, Pouwer F, de Grooth R, Holleman F, Twisk JW, Diamant M, Snoek FJ.

Diabet Med. 2011 Sep;28(9):1096-102. doi: 10.1111/j.1464-5491.2011.03329.x.

PMID:
21843305
20.

A comparison of insulin use, glycemic control, and health care costs with insulin detemir and insulin glargine in insulin-naive patients with type 2 diabetes.

Borah BJ, Darkow T, Bouchard J, Aagren M, Forma F, Alemayehu B.

Clin Ther. 2009 Mar;31(3):623-31. doi: 10.1016/j.clinthera.2009.03.005.

PMID:
19393853

Supplemental Content

Support Center